MENU

Did you miss the Medibank Private IPO? Try these 4 dividend stocks instead

Did you pass, or miss out, on the upcoming Medibank Private (ASX: MPL) IPO?

Don’t worry there’s a plethora of better opportunities for long-term investors to consider anyway.

Here are four ASX stocks for you to consider today…

1. Slater & Gordon Limited (ASX: SGH) is Australia’s largest personal injury law firm and is currently embarking on an expansion into the UK market, a market five times larger than ours. Unlike Medibank, Slater & Gordon’s potential to grow rapidly wont be hindered by intense governmental regulation. Although its dividend yield of 1.2% doesn’t compare favourably to Medibank’s forecast 3.5% yield, the sustainability and potential for increases over the long-term is a far better prospect.

2. Coca-Cola Amatil Ltd (ASX: CCL) may be on par with Medibank in regards to growth potential for the near-term, but over the long term its durable competitive advantage and cheaper price will play in shareholders’ favour. It is forecast to pay a 4.38% dividend in the next 12 months and, with the help of parent The Coca-Cola Company, CEO Alison Watkins has every intention of returning the group to sustainable earnings per share growth.

3. Super Retail Group Ltd (ASX: SUL) has like Coca-Cola had a year it’d rather forget (in 2014, so far, shares are down 42.5%). However, at today’s prices the owner of BCF, Ray’s Outdoors, Supercheap Auto and Rebel appears a better investment than Medibank, despite the softness in its Leisure retailing businesses. It yields a 5.2% fully franked dividend (that’s 7.3% grossed-up) and has achieved an average annual compound return of 13.4% over the past 10 years.

4. Computershare Limited (ASX: CPU) is an S&P/ASX 200 (INDEX^: AXJO) (ASX: XJO) company which operates on a global scale, providing share registry services (among other things) for publicly listed companies. Last week, Computershare’s stock fell 5% on news that its first half earnings per share for FY15 will be down on last year. However, the company has not changed its full year management earnings per share guidance of 5%. Longer term, Computershare has exposure to the rebounding US economy (both through operational and macroeconomic tailwinds) and a falling Australian dollar. Only 18.7% of Computershare’s revenues are derived in Australia and New Zealand.

Forget Medibank Private – Here’s our #1 stock idea for 2015 for FREE!

The Medibank Private share offer is now closed to eligible retail investors and is expected to list on the ASX on November 25. However, as noted from the better stock picks above, there’s absolutely no reason to be concerned if you missed it.

Indeed, our top investment advisor Scott Phillips recently declared another growing ASX technology company, "The Motley Fool's Top Stock for 2015" and I think it's a much better buy than Medibank Private! It's a household name Australians know and trust, offers a great dividend and is busy expanding in Asia.

Discover our analysts' hands-down favourite bet for 2015 in this brand-new FREE report. Simply click here to grab your copy.

Motley Fool Contributor Owen Raszkiewicz has registered for Medibank Private shares, owns shares of Computershare and Slater & Gordon, is long June 2016 $5.41 warrants in Coca-Cola Amatil and May 2019 $6.07 warrants in Computershare. The Motley Fool owns shares of Computershare.  

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.